CA-A Cancer Journal for Clinicians

Papers
(The median citation count of CA-A Cancer Journal for Clinicians is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Minority groups underrepresented in hematologic cancer trials17786
Breast cancer in a transgender man12929
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey7489
Cancer treatment and survivorship statistics, 20252209
2040
Issue Information2013
Near majority of adults favor R ratings for films with smoking1647
Correction to “Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline”459
Cancer statistics 2024: All hands on deck350
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians273
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer209
197
Colorectal cancer statistics, 2026175
Multicancer detection tests: What we know and what we don’t know174
Most patients with cancer are not undergoing germline genetic testing129
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies124
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types108
Cancer statistics, 2026107
Reviewer acknowledgement 2025105
104
Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach93
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review92
The evolving landscape of tissue‐agnostic therapies in precision oncology89
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicine82
81
Issue Information77
More care needed for cancer caregivers74
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial68
Health insurance status and cancer stage at diagnosis and survival in the United States66
Medicaid expansion increases survival for patients with cancer64
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future64
Interventional gastroenterology in oncology59
Study assesses normal tissue effects after axillary radiotherapy for early breast cancer53
Study identifies risk factors that may lead to secondary cancers47
Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma47
Does distance deter male fertility preservation?46
Overlooked barriers to implementation of geriatric assessment43
Lung cancer screening guidelines: Smoking matters, not quitting43
Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review42
Prostate cancer statistics, 202542
The contemporary management of cancers of the sinonasal tract in adults42
Issue Information41
Screening for lung cancer37
Cancer survivors at greater risk for bone fractures late in life36
From medical student to Editor: A note of thanks36
Bilateral mastectomy may not reduce mortality risk32
Issue Information31
Issue Information26
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance26
Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline23
Breast Cancer Statistics, 202222
Issue Information21
Chemotherapy‐induced taste changes affect nutrition, quality of life21
Cancer treatment and survivorship statistics, 202220
Prevention of device‐related infections in patients with cancer: Current practice and future horizons20
Issue Information19
19
Is active surveillance an alternative to surgery for some patients with esophageal cancer?19
18
Better communication is key for quality‐of‐life improvement in low‐income and minority patients17
Cancer misinformation on social media15
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors14
Immunotherapy combination shows longer progression‐free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer13
13
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries13
Key issues face AI deployment in cancer care13
Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer12
Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma10
Social determinants of health and US cancer screening interventions: A systematic review10
10
Geriatric assessment for the practicing clinician: The why, what, and how10
Issue Information10
Urothelial carcinoma: Perioperative considerations from top to bottom10
Global cancer statistics: A healthy population relies on population health9
Radiotheranostics in oncology: Making precision medicine possible9
Cancer statistics, 2025: A hinge moment for optimism to morph into hope?8
Global cancer statistics for children: Two decades of change and projections to 20508
Fertility counseling for reproductive‐age women with cancer should address gestational carriers8
Smoking cessation support lags behind lung cancer screenings8
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach8
Is mandated genetic counseling needed?7
Carcinoma of unknown primary: Molecular tumor board‐based therapy7
7
Cancer statistics for A merican I ndian and A l6
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer6
Correction to “Advances in the noninvasive diagnosis of melanoma—40 years beyond the ABCDs”6
Reviewer acknowledgement 20226
Sustained weight loss may reduce cancer risk5
Issue Information5
Issue Information5
Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer5
New studies examine COVID ‐19 risks among cancer patients5
Cancer disparities for LGBTQ+ patients identified more fully5
The evolving landscape of salivary gland tumors5
Regorafenib as maintenance therapy showed significant delayed progression of non‐adipocytic soft tissue sarcomas4
Study identifies signs and symptoms of colorectal cancer risk at younger ages4
Not only a Western world issue: Cancer incidence in younger individuals in the United Arab Emirates3
3
Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management3
Issue Information3
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer3
Update and new advances in fertility preservation and cancer3
3
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial3
3
Consensus and controversy in advanced urologic cancers: Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 20253
Erectile dysfunction common within the first year after rectal cancer surgery2
Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology2
Pursuit of precision oncology in the treatment of metastatic hormone receptor–positive breast cancer: Making strides or barely moving?2
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians2
Erratum to “Cancer statistics, 2024”2
Issue Information2
Colon cancer blood test effective for average‐risk population2
Osimertinib prolongs progression‐free lung cancer survival after chemotherapy2
Issue Information2
Cancer statistics for African American and Black people, 20252
2
Issue Information2
A patient with newly diagnosed breast cancer found to have mosaic TP53 likely pathogenic variant2
MCED blood test boosts cancer detection in symptomatic patients1
Issue Information1
Cancer statistics, 20251
Cancer in rural America: Improving access to clinical trials and quality of oncologic care1
The association between menopausal hormone therapy and breast cancer remains unsettled1
Breast cancer statistics 20241
1
Colonoscopies for patients aged 45–49 years yield positive results1
Clinician communication strategies associated with increased uptake of the human papillomavirus ( HPV ) vaccine: A systematic review1
Targeting tumor suppressor gene co‐mutations in EGFR ‐mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification1
Most young female cancer survivors are at minimal risk for obstetric problems1
Correction to “American Cancer Society’s report on the status of cancer disparities in the United States, 2025”1
Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker‐dri1
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature1
People experiencing homelessness face inpatient care disparities1
1
Learning from prostate cancer statistics1
Immunosurveillance in clinical cancer management1
Examining the interrelationships between mindfulness‐based interventions, depression, inflammation, and cancer survival1
Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack‐year history: A systematic review1
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 20191
Cancer care for people with dementia: Literature overview and recommendations for practice and research1
Breast cancer survivors face greater cardiometabolic risks1
Cancer statistics, 2026: Charting a course for a national cancer research agenda1
Correction to “Cancer treatment and survivorship statistics, 2025”1
Multidisciplinary considerations in the maintenance treatment of poly(ADP‐ribose) polymerase inhibitors for homologous recombination‐proficient, advanced‐stage epithelial ovarian cancer1
1
1
Treatment adaptation based on response to induction chemotherapy in nasopharyngeal carcinoma: An evolving landscape1
Reviewer acknowledgement 20231
Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 20221
Nonpharmacologic interventions for managing distress, anxiety, and depression for patients with cancer and their family caregivers: A systematic review and meta‐analysis1
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer1
2.3846399784088